Quadridox, Inc.’s Post

Check out how Jacob Ahrnstein and Njord Medtech are ensuring safe and efficient patient transfer in acute care: https://lnkd.in/dF_8ASP7 #patienthandling #acutecare #radiology #sustainablehealthcare

Learn more about how Njord Medtech is improving and creating a more resilient healthcare system with co-bot solutions and the Atle® 180. ❤️ Who We Are: We're a European based medtech company having developed and launched a novel patient transfer device (co-bot solution) specifically targeted at radiology departments and acute care. ⚠️Key Problem: Today’s lateral transfer within acute care are manual intense leads to work injuries, stress, and an inefficient workflow. 🏅Our Solution: The Atle® 180 enables patient transfer with a touch-of-a-button while securing a safe and patient friendly transfer at acute care departments such as radiology, interventional radiology, radiotherapy, and surgery. 🤝Join Us on This Journey: Njord is dedicated to solving unmeet needs in patient handling and radiology building a more resilient healthcare system with satisfied patients. If you’re interested in our vision, let’s connect! Link to video: https://lnkd.in/dF_8ASP7 BioStock - Connecting Innovation and Capital Jacob Ahrnstein #patienthandling #acutecare #radiology #sustainablehealthcare

🌟 Lumea's new products are now out on Pathology News! 🌟 We're excited to showcase these game-changing tools—dive into these innovative solutions and elevate your lab’s performance: 🔹 Lumea BxAlign: Boost slide scanning accuracy by reducing rescans and ensuring consistent positioning for small biopsies and cytology samples. This tool empowers pathologists to compare multiple specimen levels and stains simultaneously, enhancing diagnostic efficiency. 🔹 BxChip: A patented Sectionable Matrix that securely holds core needle biopsies throughout lab processing. 🔹 FocalRing®: A specialized tool that minimizes scanning failures and rescans caused by poor focal plane definition in small tissue biopsies and cytology samples, ensuring reliable whole slide scanning results. Explore these solutions and enhance your lab's diagnostic capabilities! 🔬✨ Visit Lumea's page on Pathology News to learn more: https://lnkd.in/e9ntxsGw #PathologyNews #LumeaInnovation #LabSolutions #DiagnosticEfficiency

𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐨𝐟 𝐃𝐢𝐠𝐢𝐭𝐚𝐥 𝐏𝐚𝐭𝐡𝐨𝐥𝐨𝐠𝐲: 𝐓𝐫𝐞𝐧𝐝𝐬 & 𝐅𝐮𝐭𝐮𝐫𝐞 𝐒𝐜𝐨𝐩𝐞 𝐆𝐞𝐭 𝐚 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐆𝐮𝐢𝐝𝐞: https://lnkd.in/dcaTKx4p The digital pathology market is poised for significant growth, with projections indicating that it will reach USD 1.91 billion by the year 2031 and achieve a compound annual growth rate (CAGR) of 7.8%. This growth can be attributed to several key factors, including advancements in technology, increasing prevalence of chronic diseases, and the need for more efficient diagnostic processes in healthcare settings. Digital pathology offers numerous advantages over traditional microscopy methods, such as improved accuracy, efficiency, and remote access to images for collaboration and consultation. As healthcare providers continue to adopt digital pathology solutions, the market is expected to expand rapidly in the coming years. With ongoing research and development efforts aimed at enhancing these technologies further, the future looks bright for the digital pathology market as it continues to revolutionize the field of diagnostics. Major Players Profiled in Report: 3DHISTECH - The Digital Pathology Company aetherAI 雲象科技 Apollo Enterprise Imaging Corp Bionovation Biotech Inc. CellaVision ContextVision AB Epredia 浜松ホトニクス株式会社 - Hamamatsu Photonics K.K. Morphogo Huron Technologies, Inc. Ibex Medical Analytics Inspirata Visiopharm Philips Leica Biosystems Mikroscan Technologies, Inc. Morphle Labs Inc. Olympus Corporation PerkinElmer Roche SigTuple West Medica Produktions- und Handels- GmbH #DigitalPathology #Pathology #HealthcareTechnology #MedicalImaging #Histopathology #Telepathology #DigitalHealthcare #AIinPathology #DigitalDiagnostics #MedicalTechnology #ClinicalPathology #HealthcareInnovation #LabDiagnostics #MedicalResearch #DigitalHealth #3DHISTECH #aetherAI #ApolloEnterpriseImaging #BionovationBiotech #CellaVision #ContextVision #Epredia #HamamatsuPhotonics #Morphogo #HuronTechnologies #IbexMedicalAnalytics #Inspirata #Visiopharm #Philips #LeicaBiosystems #MikroscanTechnologies #MorphleLabs #Olympus #PerkinElmer #Roche #SigTuple #WestMedica

A New #Embolic for #MSK Unveiled at #ET2024? 🕵️♂️ 1/ 🧵 @YujiOkuno_OC et al. published the abstract "The future of #MSK embolotherapies: imageable biodegradable microspheres" Here is what we know about these biodegradable microspheres so far: 2/ 🎯 Purpose: An international team is investigating a novel embolic material that is rapidly dissolving, radiopaque, and echogenic, intended for musculoskeletal use. 🌍 #HealthTech 3/ 🧪 Methodology: These microspheres, are made from networked inorganic polymers (75-150 micron) and are designed to be visible on angiograms/CT and undergo "rapid dissolution via hydration and hydrolysis". 📊🩺 #MedicalResearch 4/ Through superselective transcatheter embolization in testing models, researchers evaluated the microspheres' effectiveness, injectability, and imaging capabilities. 🧑🔬🚀 #ClinicalTrials 5/ 🌟 Impact: The visibility of these microspheres was confirmed by multiple physicians on angiograms AND ultrasound! 💡🔎 #FutureOfMedicine 6/ 🔄 Next Steps: Further clinical evaluations are planned to assess the viability of this technology. #MSKEmbo data continues to evolve and so does the debate on #temporary vs. #permanent #embolics for #MSK #embolotherapy! 7/ What are your thoughts? @marklittle_IR @TheRealDoctorOs @SandeepBaglaMD @AriIsaacsonMD @thegestgroup @cirsesociety #GAE #KneePain #Ortho Follow us to stay up-to-date with the latest in #VIR #iRads! Subscribe to our newsletter: https://lnkd.in/gRwAjsEf

🌟 𝐓𝐫𝐚𝐧𝐬𝐟𝐨𝐫𝐦𝐢𝐧𝐠 𝐓𝐢𝐬𝐬𝐮𝐞 𝐄𝐧𝐠𝐢𝐧𝐞𝐞𝐫𝐢𝐧𝐠: 𝐓𝐡𝐞 𝐄𝐂𝐌 𝐆𝐞𝐥 𝐌𝐚𝐫𝐤𝐞𝐭 🌟 𝐂𝐥𝐢𝐜𝐤 𝐇𝐞𝐫𝐞, 𝐓𝐨 𝐆𝐞𝐭 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://lnkd.in/dQE8dKz8 The ECM Gel Market is revolutionizing tissue engineering and regenerative medicine, providing a versatile and innovative solution for promoting cell growth and tissue repair. ECM gels, derived from the extracellular matrix, are essential in developing advanced therapies and improving clinical outcomes. 🌟 Key Highlights: Natural Support: ECM gels mimic the natural extracellular matrix, providing a supportive environment for cell adhesion, proliferation, and differentiation, essential for successful tissue regeneration. Versatility: These gels are used in various applications, including wound healing, organ repair, and regenerative medicine, offering broad therapeutic potential. Biocompatibility: Derived from natural sources, ECM gels are highly biocompatible, minimizing the risk of immune reactions and enhancing patient safety. 📈 Market Dynamics: Growing Applications: The increasing demand for advanced regenerative therapies and tissue engineering solutions is driving the growth of the ECM gel market. Technological Advancements: Innovations in ECM gel formulation and production techniques are expanding their applications and improving their effectiveness in clinical settings. Research and Development: Ongoing research is exploring new applications and improving the performance of ECM gels, driving further market expansion. #Company Corning Thermo Fisher Scientific DSM Biomedical CellSystems® #Type • Porcine • Bovine • Others #Application • 2D Cell Culture • 3D Cell Culture #ECMGel #TissueEngineering #RegenerativeMedicine #HealthcareInnovation #CellTherapy #MedicalResearch #Biocompatibility #LinkedInPost

💡Proud to share that I am the first co-author of our latest publication in Advanced Materials! 💡"3D Bioprinting for Engineered Tissue Constructs and Patient-Specific Models: Current Progress and Prospects in Clinical Applications," explores the transformative potential of advanced 3D bioprinting in tissue engineering and personalized medicine. 💡This study highlights advancements in bioprinting techniques and addresses the remaining challenges in scaling tissue constructs and clinical relevancy. Through continued research and interdisciplinary collaboration, 3D bioprinting holds immense potential for developing functional, transplantable tissues and advanced in vitro models for clinical applications. #Advanced3DBioprinting #TissueEngineering #RegenerativeMedicine #PersonalizedMedicine

What’s the difference between 2D and #3dcellculture? While 2D cell culture is convenient for cell analysis, 3D cell culture has the ability to mimic the exact environment of tissues, decreasing the need for animal testing and providing results that will improve the translation from in-vitro to in-vivo studies. Humabiologics offers native human-derived biomaterials to mimic the native tissue-specific environment for regenerative medicine and tissue engineering applications such as 2D and 3D cell culture that will help develop lifesaving therapies. Learn more about our product offerings here: https://lnkd.in/e-pi48RE #collagen #ISO13485 #gelatin #tissueengineering 

Minute in Medtech: A perspective from an aspiring Biomedical Engineer, Competitive Cyclist, CHD Warrior, and typical(?) Teen... In the previous edition of #minuteinmedtech, I discussed the Garmin Edge 530, a device used by cyclists to monitor all forms of data. Today, I will discuss the Vascular Perfusion Solutions, Inc. Encore, an organ transport device promising a solution to organ shortages, challenging conventional preservation methods. Unlike the standard of care, reliant on ice cooling, the Encore uses a non-blood, nutrient-rich perfusate solution to extend organ viability. The Encore is capable of modification for various organs and vascularized tissues. The Encore can be impactful with its innovative preservation system by expanding the donor pool. Data shows that the device has the potential to optimize organ matching, increase health post-transplant, and mitigate rejection issues in many. The device preserves organs; it aspires to make them more viable, compatible, and successful in transplantation. The importance of organ security while in transit is vital. Although I have never had an organ transplant surgery, the cardiovascular innovation presented by VPS is inspiring. Any cardiovascular innovation is particularly calling to me with my story as a congenital heart defect warrior. It is awesome to see VPS cultivate a design so new and unconventional. I could see a Lamborghini Hurucan using the VPS Encore to transport a vital organ at 200+ miles an hour in Italy. The device is currently in its developmental stages but is making many strives to get on the market. Thanks for reading! If you are interested in more of what Vascular Perfusion Solutions is doing, check them out using this link: https://lnkd.in/dSxthqn3 Follow me at #MinuteinMedtech for more innovative and interesting medical devices. To note, this is my opinion and I am not being compensated for this post. Rafael J. Veraza, PhD, MPH

𝐄𝐱𝐜𝐢𝐭𝐢𝐧𝐠 𝐝𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐀𝐫𝐭𝐢𝐟𝐢𝐜𝐢𝐚𝐥 𝐓𝐢𝐬𝐬𝐮𝐞 𝐌𝐚𝐫𝐤𝐞𝐭! 𝐆𝐞𝐭 𝐚 𝐅𝐑𝐄𝐄 𝐬𝐚𝐦𝐩𝐥𝐞: https://lnkd.in/gDuGPXg8 As technology continues to advance, so does our ability to create innovative solutions in healthcare. Artificial tissue, once a futuristic concept, is now becoming a reality, revolutionizing the medical field. From synthetic skin for burn victims to lab-grown organs for transplantation, the potential applications of artificial tissue are limitless. Not only does it offer hope to patients in need of organ replacements, but it also reduces the dependency on donor organs, addressing the growing gap between supply and demand. Investment in research and development is driving the rapid growth of this market, with breakthroughs happening regularly. Companies are pushing the boundaries of what's possible, bringing us closer to a future where complex surgeries are safer, recovery times are shorter, and lives are saved. The artificial tissue market comprises various market players such as TISSUE REGENIX GROUP PLC, Baxter International Inc., Integra LifeSciences, Allergenis, Zimmer Biomet, Becton, Dickinson and Company, Wright Medical Group N.V., American CryoStem Corporation, and Asterias Biotherapeutics. Join us in keeping an eye on this space as we witness the transformation of healthcare through artificial tissue technology! #artificialtissue #healthcareinnovation #medicaltechnology